Zocor OTC Switch Sought In U.K.; Merck’s First Choice For U.S. Is Mevacor
Executive Summary
Merck continues to favor Mevacor as its primary OTC switch candidate for the U.S. statin market despite a favorable recommendation by the British Department of Health to sell Zocor over the counter in the U.K